Item 2 of 119 (back to results) previous next   alpha-benzyl-N-methylphenethylamine C006733               MeSH Unique Identifier: C006733 Scope Notes: Impurity by-product of methamphetamine synthesis; identified in illicit methamphetamine samples Click here for more information

Current search: C10. Nervous System Diseases: Nervous System Diseases [MESH:D009422] > Neurodegenerative Diseases [MESH:D019636] > Parkinson Disease [MESH:D010300] > Parkinsonism-Dystonia, Infantile [MESH:C567730] × Select any link to see items in a related category. more general categories    information about this item C10. Nervous System Diseases  C10. Nervous System Diseases  Z. Exceptions (4027)   Not Fully Specified [NFS] (4027)  Nervous System Diseases [MESH:D009422] (13325)   Central Nervous System Diseases [MESH:D002493] (9745)   Brain Diseases [MESH:D001927] (9294)   Dementia [MESH:D003704] (4498)  Basal Ganglia Diseases [MESH:D001480] (4268)   Parkinsonian Disorders [MESH:D020734] (4009)   Parkinson Disease [MESH:D010300] (3595)   Parkinsonism-Dystonia, Infantile [MESH:C567730] (119)  Epilepsy [MESH:D004827] (6274)   Epilepsy, Generalized [MESH:D004829] (1431)   Epilepsy, Tonic-Clonic [MESH:D004830] (1042)  Movement Disorders [MESH:D009069] (4823)   Tic Disorders [MESH:D013981] (256)  Dystonic Disorders [MESH:D020821] (729)   Parkinsonism-Dystonia, Infantile [MESH:C567730] (119)  Parkinsonian Disorders [MESH:D020734] (4009)   Parkinson Disease [MESH:D010300] (3595)   Parkinsonism-Dystonia, Infantile [MESH:C567730] (119)  Neurodegenerative Diseases [MESH:D019636] (6613)   Parkinson Disease [MESH:D010300] (3595)   Parkinsonism-Dystonia, Infantile [MESH:C567730] (119)  Neurologic Manifestations [MESH:D009461] (8964)   Dyskinesias [MESH:D020820] (3365)   Hyperkinesis [MESH:D006948] (1799)  Neurobehavioral Manifestations [MESH:D019954] (5230)   Memory Disorders [MESH:D008569] (3233) C23. Pathological Conditions, Signs and Symptoms  C23. Pathological Conditions, Signs and Symptoms  Pathologic Processes [MESH:D010335] (9863)   Nerve Degeneration [MESH:D009410] (4061)  Chromosome Aberrations [MESH:D002869] (2352)   Micronuclei, Chromosome-Defective [MESH:D048629] (1013)  Signs and Symptoms [MESH:D012816] (10659)   Neurologic Manifestations [MESH:D009461] (8702)   Dyskinesias [MESH:D020820] (3285)   Hyperkinesis [MESH:D006948] (1799)  Neurobehavioral Manifestations [MESH:D019954] (4706)   Memory Disorders [MESH:D008569] (3233) C25. Chemically-Induced Disorders  C25. Chemically-Induced Disorders  Poisoning [MESH:D011041] (6703)   Psychoses, Substance-Induced [MESH:D011605] (2053)  Substance-Related Disorders [MESH:D019966] (6308)   Amphetamine-Related Disorders [MESH:D019969] (2858)  Cocaine-Related Disorders [MESH:D019970] (3054)  Psychoses, Substance-Induced [MESH:D011605] (2052) D02. Organic Chemicals  D02. Organic Chemicals  Organic Chemicals [MESH:D009930] (75987)   Amines [MESH:D000588] (7350)   Ethylamines [MESH:D005021] (854)   Phenethylamines [MESH:D010627] (503)   Amphetamines [MESH:D000662] (182)   Methamphetamine [MESH:D008694] (43) F. Psychiatry and Psychology  F. Psychiatry and Psychology  Mental Disorders [MESH:D001523] (2063)   Mood Disorders [MESH:D019964] (257)   Affective Disorders, Psychotic [MESH:D000341] (248)   Bipolar Disorder [MESH:D001714] (247)   Major Affective Disorder 1 [MESH:C565111] (237)